Finance

Beta
Lists
VTRS:NASDAQ
Viatris Inc
$16.18
+1.89%
(+0.30) 1D
$16.18
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTRS...
Open
$16.03
High
$16.34
Low
$15.92
Mkt. cap
18.84B
Avg. vol.
10.15M
Volume
13.24M
Dividend
2.97%
Quarterly dividend
$0.12
Ex-dividend date
May 22, 2026
52-wk high
$17.53
52-wk low
$8.62
EPS
-$0.26
Beta
0.90
Shares outstanding
1.16B
No. of employees
30K
Open
$16.03
High
$16.34
Low
$15.92
Mkt. cap
18.84B
Avg. vol.
10.15M
Volume
13.24M
Dividend
2.97%
Quarterly dividend
$0.12
Ex-dividend date
May 22, 2026
52-wk high
$17.53
52-wk low
$8.62
EPS
-$0.26
Beta
0.90
Shares outstanding
1.16B
No. of employees
30K
News stories
From sources across the web
Profile
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
About Viatris Inc
CEOScott A. Smith
Employees30K
FoundedNov 16, 2020
HeadquartersCanonsburg, Pennsylvania, United States
SectorPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to VTRS in the past 3 months
Buy
Buy
2
Hold
3
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for VTRS in the last 3 months.
Highest
Current $16.18
$22.00 (+35.97%)
Average
$17.60 (+8.78%)
Lowest
$12.00 (-25.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Amsellem
Piper Sandler
Hold
Maintained
$12.00
-25.8%
06/04/2026
Glen Santangelo
Barclays
Buy
Reiterated
$22.00
+36%
05/18/2026
Chris Schott
J.P. Morgan
Hold
Reiterated
$18.00
+11.2%
05/08/2026
Les Sulewski
Truist Financial
Buy
Reiterated
$20.00
+23.6%
05/08/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
$16.00
-1.1%
05/04/2026
Unknown Analyst
Jefferies
Buy
Maintained
$17.00
+5.1%
03/20/2026
Ashwani Verma
UBS
Buy
Maintained
$20.00
+23.6%
02/27/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.59 / $0.50
+17.54%beat
Revenue / Est. (USD)
3.52B / 3.36B
+4.77%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.58B
3.76B
3.70B
3.52B
Cost of goods sold
2.15B
2.26B
2.21B
2.14B
Cost of revenue
2.15B
2.26B
2.21B
2.14B
Research and development expenses
216.00M
244.80M
271.20M
245.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
857.30M
848.50M
933.40M
893.40M
Operating expense
1.07B
1.09B
1.20B
1.14B
Total operating expenses
3.23B
3.36B
3.42B
3.28B
Operating income
356.40M
404.60M
288.20M
238.60M
Other non operating income
-110.40M
-135.90M
44.90M
-1.80M
EBT including unusual items
-217.10M
-7.90M
-343.00M
-247.30M
EBT excluding unusual items
254.70M
318.70M
188.00M
146.20M
Income tax expense
-212.50M
120.30M
-2.90M
-423.70M
Effective tax rate
97.88%
-1,522.78%
0.85%
171.33%
Other operating expenses
-
-
-
-
Net income
-4.60M
-128.20M
-340.10M
176.40M
Net profit margin
-0.13%
-3.41%
-9.18%
5.02%
Earnings per share
0.62
0.67
0.57
0.59
Interest and investment income
-
-
-
-
Interest expense
-116.60M
-119.60M
-119.60M
-120.10M
Net interest expenses
-116.60M
-119.60M
-119.60M
-120.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.03B
1.09B
981.10M
914.70M
Gain or loss from assets sale
43.80M
-1.60M
21.90M
13.90M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more